circRNA basic information
circBase ID: hsa_circ_0082002
Name: hsa_circ_MET
Synonym: circMET
Host Gene: MET
Genomic location(hg19): chr7:116339124-116340338:+
Genomic location(hg38): chr7:116699070-116700284:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; adjacent nontumor liver tissues; tumor tissues; paratumor tissues; blood

Cell lines:

HCCLM3; Huh7; Hep3B; HepG2; Hep1-6; HEK293T; 293 T

In vivo animal model:

syngeneic model

circRNA-disease information
Expression pattern:
UP
Associated gene: Snail, dipeptidyl peptidase 4(DPP4), CXCL10
Associated microRNA: miR-30a-5p, miR-30b-5p, miR-30c-5p, miR-30d-5p, miR-30e-5p
Biological function: Promotes HCC invasion and metastasis, induces EMT, and promotes an immunosuppressive tumor microenvironment with reduced CD8+ T cell infiltration; contributes to anti-PD1 therapy resistance.
Molecular mechanism: Acts as a miRNA sponge for the miR-30-5p family, relieving repression of Snail; Snail transcriptionally upregulates DPP4, which reduces CXCL10 and limits CD8+ T cell trafficking, creating immunosuppression and resistance to anti-PD1 therapy.
Biological pathway or process:

EMT (promotes); invasion (promotes); metastasis (promotes); immune regulation (inhibits); chemokine signaling pathway (other); PI3K/AKT (other); ceRNA regulation (promotes)

Detected method:
Q
H
Validation methods:

RT-qPCR; ISH (In Situ Hybridization); Clinical Sample Validation; Cohort Study; Survival Analysis; circRIP; RNA Pull-Down; Luciferase Reporter Assay; FISH / smFISH; Transfection; Transwell Assay; Wound Healing Assay; Colony Formation Assay; MTT; Cell Cycle Assay; RNA-seq; ChIP / ChIP-seq; ELISA; IHC (Immunohistochemistry); In Vivo Animal Model

Clinical significance:

High circMET expression is associated with poor overall survival and higher cumulative recurrence rates; circMET expression is an independent predictor of OS and postoperative recurrence in HCC.

Description:

circMET (hsa_circ_0082002), derived from MET, is up-regulated in HCC and predicts worse survival and higher recurrence. Functionally, circMET promotes invasion/metastasis and EMT while suppressing antitumor immunity by sponging the miR-30-5p family to increase Snail and downstream DPP4, reducing CXCL10 and CD8+ T-cell infiltration, contributing to anti-PD1 resistance.

Confidence score:

0.8283

Other information
Title:

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Journal: Molecular cancer
Published: 2020
PubMed ID: 32430013
Study type:

combined biological and clinical study

Data availability: -
Code availability: -